Finance

Lists
ACH:NYSE
Accendra Health Inc
$1.06
-0.93%
(-0.010) 1D
Sep 10, 1:28:47 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACH...
Open
$1.05
High
$1.07
Low
$0.96
Mkt. cap
81.90M
Avg. vol.
1.73M
Volume
577.41K
52-wk high
$4.69
52-wk low
$0.93
EPS
-$3.93
Beta
1.53
Shares outstanding
76.90M
No. of employees
6K
Open
$1.05
High
$1.07
Low
$0.96
Mkt. cap
81.90M
Avg. vol.
1.73M
Volume
577.41K
52-wk high
$4.69
52-wk low
$0.93
EPS
-$3.93
Beta
1.53
Shares outstanding
76.90M
No. of employees
6K
Profile
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019. Wikipedia
About Accendra Health Inc
CEOEdward A Pesicka
Employees6.5K
Founded1882
Headquarters-
SectorHealth care provider
Websiteaccendrahealth.com
Analyst ratings
Based on 4 analysts giving stock ratings to ACH in the past 3 months
Hold
Buy
0
Hold
3
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ACH in the last 3 months.
Highest
Current $1.06
$1.50 (+41.51%)
Average
$1.45 (+36.79%)
Lowest
$1.30 (+22.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin Caliendo
UBS
Hold
Maintained
$1.50
+41.5%
08/13/2026
Allen Lutz
Bank of America Securities
Sell
Maintained
$1.30
+22.6%
08/11/2026
Eric Coldwell
Robert W. Baird
Hold
Downgraded
$1.50
+41.5%
08/11/2026
Daniel Grosslight
Citi
Hold
Downgraded
$1.50
+41.5%
08/11/2026
Last report
Aug 10, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.19 / -$0.09
-116.01%miss
Revenue / Est. (USD)
613.23M / 627.37M
-2.25%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
697.26M
708.97M
627.78M
613.23M
Cost of goods sold
375.07M
385.71M
349.75M
349.83M
Cost of revenue
375.07M
385.71M
349.75M
349.83M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
265.84M
273.20M
255.23M
243.56M
Operating expense
265.84M
302.42M
284.46M
272.79M
Total operating expenses
640.90M
688.13M
634.21M
622.62M
Operating income
56.36M
20.83M
-6.43M
-9.38M
Other non operating income
-1.08M
747.00K
-1.02M
-643.00K
EBT including unusual items
-3.64M
-7.97M
-16.25M
-87.63M
EBT excluding unusual items
26.25M
-6.35M
-39.80M
-44.56M
Income tax expense
1.97M
1.47M
-9.78M
1.44M
Effective tax rate
-54.25%
-18.47%
60.19%
-1.65%
Other operating expenses
-
-
-
-
Net income
-150.28M
-56.33M
-6.47M
-89.07M
Net profit margin
-21.55%
-7.94%
-1.03%
-14.52%
Earnings per share
0.25
0.21
-0.04
-0.19
Interest and investment income
-
-
-
-
Interest expense
-29.03M
-27.93M
-32.35M
-34.54M
Net interest expenses
-29.03M
-27.93M
-32.35M
-34.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
120.46M
50.71M
55.32M
56.32M
Gain or loss from assets sale
-7.06M
-10.89M
-55.51M
-3.27M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps